Precision immunophenotyping by high-throughput TCR sequencing in human glioma

摘要: Meeting abstracts Immunotherapy for glioblastoma (GBM) is the subject of numerous clinical trials, given potential adaptive immune response to combat this diffusely infiltrating tumor. However, rational application immunotherapy these tumors challenging because peculiar